Casey Murphy has fanned his passion for finance through years of writing about active trading, technical analysis, market commentary, exchange-traded funds (ETFs), commodities, futures, options, and ...

The best midnight movies conjure a community experience, pleasing audiences who want to see reactions to the insanity onscreen. While many touchstones of the genre consist of notoriously strange and ...

Sky Mavis’ Axie Infinity is back with a new web3 MMO coming to mobile and PC titled Axie Infinity: Atia’s Legacy. The game is expected to feature squad-based real-time battles, crafting, side quests ...

Add Decrypt as your preferred source to see more of our stories on Google. The makers of seminal play-to-earn game Axie Infinity just announced the franchise’s new massively multiplayer online—or ...

Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...

Functional programming, as the name implies, is about functions. While functions are part of just about every programming paradigm, including JavaScript, a functional programmer has unique ...

Axie Infinity’s website traffic rose by 11% in October. The Unique Active Wallets have risen in the past few weeks. There are odds that the coin may jump by 50% from the current level. Axie Infinity ...

Callum is a seasoned gaming managing editor for a number of publications and a gamer who will always try to shine a spotlight on indie games before giving AAA titles the time of day. He loves nothing ...

Sixty years ago, on May 1, 1964, at 4 am in the morning, a quiet revolution in computing began at Dartmouth College. That’s when mathematicians John G. Kemeny and Thomas E. Kurtz successfully ran the ...

Sam has loved video games and writing for as long as they can remember. When they aren't gaming or writing, they can be found watching motorsports and ice hockey. Tutorials are often the least ...

Infinity Pharmaceuticals was developing eganelisib in several midstage studies, including in urothelial cancer and in solid tumors. (Auris/iStock/Getty Images Plus) After a merger with MEI Pharma was ...